Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers created new cell models for sickle cell disease and beta-thalassemia using CRISPR/Cas9. These models mimic disease features and show promise for developing new treatments and therapies.
Area Of Science
- Erythroid biology
- Hematology
- Gene editing
Background
- Accurate ex vivo cellular models for sickle cell disease (SCD) and beta-thalassemia are crucial for research.
- Existing models often fail to fully replicate disease complexity.
Purpose Of The Study
- To generate novel erythroid progenitor cell lines modeling SCD and beta-thalassemia using CRISPR/Cas9 gene editing.
- To establish a physiologically relevant platform for disease study and therapeutic development.
Main Methods
- CRISPR/Cas9 gene editing was employed to introduce SCD and beta-thalassemia mutations into erythroid progenitor cells.
- Characterization of differentiation, globin expression, and proteome dynamics was performed.
- Assessment of disease phenotype recapitulation and response to therapeutic agents.
Main Results
- Generated erythroid progenitor lines accurately mimic SCD and beta-thalassemia characteristics.
- Cellular models display similar differentiation, globin expression, and proteome dynamics to patient-derived cells.
- Hydroxyurea and pomalidomide treatments increased fetal hemoglobin (HbF) levels.
- Recapitulation of the HPFH3 genotype reactivated HbF and rescued disease phenotypes.
Conclusions
- The developed cellular systems are physiologically relevant and valuable for SCD and beta-thalassemia research.
- These models serve as a robust platform for drug screening and the development of cell and gene therapies.
- This work advances the potential for innovative therapeutic strategies for hemoglobinopathies.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
iPSCs have been successfully used to treat age-related macular degeneration (AMD), a form of...
The Concept of Multiple Allelism
Multiple allelism describes genes that exist in three or more allelic forms. Although diploid organisms, like humans, normally possess only two alleles of each gene, there are multiple alleles of many (if not most) human genes present in a population. Blood type is one example of multiple allelism. There are three alleles for blood type (HBB gene) in humans: IA, IB, and i.
Incomplete Dominance
Sickle cell anemia, which is caused by a mutation in the gene...